Literature DB >> 34247853

Omalizumab in chronic inducible urticaria: A retrospective, real-life study.

M Fialek1, F Dezoteux2, A Le Moing3, E Karimova3, N Ramdane4, E Pape3, S Azib-Meftah3, D Staumont-Sallé2.   

Abstract

Entities:  

Keywords:  Cholinergic urticaria; Cold urticaria; Delayed pressure urticaria; Inducible urticaria; Omalizumab

Mesh：

Substances：

Year:  2021        PMID： 34247853     DOI： 10.1016/j.annder.2021.04.010

Source DB:  PubMed          Journal:  Ann Dermatol Venereol        ISSN： 0151-9638            Impact factor:   0.777


× No keyword cloud information.
  2 in total

1.  Multicentric and Observational Study of Omalizumab for Chronic Spontaneous Urticaria in Real-Life in Colombia.

Authors:  Elizabeth García-Gómez; Edgardo Chapman; María Beatriz García-Paba; Jaime Ocampo-Gómez; Eduardo Egea-Bermejo; Gloria Garavito-De Egea; Luis Fang; Mauricio Sarrazola; Jorge Mario Sánchez-Caraballo; Carlos Serrano-Reyes; Diana Lucia Silva-Espinosa; Dolly Vanessa Rojas-Mejía; Sergio M Moreno
Journal:  Front Allergy       Date:  2022-05-20

2.  Omalizumab on Chronic Spontaneous Urticaria and Chronic Inducible Urticaria: A Real-World Study of Efficacy and Predictors of Treatment Outcome.

Authors:  Soo Hyun Jeong; Dong Jun Lim; Sung Eun Chang; Kwang Ho Kim; Kwang Joong Kim; Eun Joo Park
Journal:  J Korean Med Sci       Date:  2022-07-11       Impact factor: 5.354
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.